Friday, October 07, 2022 3:07:09 PM
This morning, we received a cost basis of $6.49 for each new share. We sold none.
Recent BHVN News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/09/2024 08:16:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:14:14 PM
- Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments • PR Newswire (US) • 05/09/2024 08:05:00 PM
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 04/22/2024 08:05:00 PM
- Biohaven Announces Proposed Public Offering of Common Shares • PR Newswire (US) • 04/17/2024 08:05:00 PM
- Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates • PR Newswire (US) • 04/13/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:16:45 PM
- Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments • PR Newswire (US) • 02/29/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:30:54 PM
- Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncolo • PR Newswire (US) • 01/08/2024 12:30:00 PM
- Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/02/2024 12:00:00 PM
- Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting • PR Newswire (US) • 12/01/2023 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:15:28 PM
- Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments • PR Newswire (US) • 11/14/2023 09:05:00 PM
- Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek® • PR Newswire (US) • 10/16/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:05:27 PM
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 10/05/2023 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/04/2023 08:05:45 PM
- Biohaven Announces Pricing of $225 Million Public Offering of Common Shares • PR Newswire (US) • 10/03/2023 03:56:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 01:41:44 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/02/2023 09:09:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/02/2023 09:07:23 PM
- BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES • PR Newswire (US) • 10/02/2023 08:36:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 10/02/2023 08:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 10:58:58 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM